Biofrontera Inc.BFRI
...Loading BFRI Peers...
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
83 Employees
CEO : Dr. Hermann Luebbert Ph.D.
Address : 120 Presidential Way, Woburn,MA, US, - 01801,
| Key Excutives | Designation |
|---|---|
| Mr. Daniel Hakansson J.D. | General Counsel & Head of Compliance |
| Dr. Hermann Luebbert Ph.D. | Chief Executive Officer, President & Executive Chairman |
| Mr. Eugene Frederick Leffler III | Chief Financial Officer |
| Ms. Alycia Torres | Vice President of Administration |
| Mr. Mark Baldyga | Vice President of Sales & Marketing |
| Ms. Erica F. Gates CPA, M.B.A. | Senior Director of Finance & Principal Accounting Officer |
| Mr. Jon Lyons M.B.A., Ph.D. | Vice President of Scientific & Medical Affairs |